Table 3. Proportional hazards general... | American Society of Hematology

Table 3.

Proportional hazards general linear model of potential influential factor of cytogenetic relapse of CML after BMT

Factors	Univariate^3-150	Multivariate^3-151
Patient age	.448	—
Interval diagnosis to BMT	.290	—
Clinical phase at BMT	.405	—
Myeloablative regimen	.815	—
GVHD prophylaxis	.243	—
T-cell depletion	.015	.8538
Acute GVHD	.088	—
Chronic GVHD	.036	.1083
P210^BCR-ABL	< .0001	.6391
P190^BCR-ABL	< .0001	.0020
Myeloid cell MC	< .0001	.0822
T-cell MC	.0003	.7195

Factors	Univariate^3-150	Multivariate^3-151
Patient age	.448	—
Interval diagnosis to BMT	.290	—
Clinical phase at BMT	.405	—
Myeloablative regimen	.815	—
GVHD prophylaxis	.243	—
T-cell depletion	.015	.8538
Acute GVHD	.088	—
Chronic GVHD	.036	.1083
P210^BCR-ABL	< .0001	.6391
P190^BCR-ABL	< .0001	.0020
Myeloid cell MC	< .0001	.0822
T-cell MC	.0003	.7195

Significances are derived by the log-rank test of event distribution functions across stratified factors.

Significances are derived from the proportional hazards general linear model analysis for significant factors included in model building.